Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Serum Institute of India

Novavax Makes Big Move Donating 1.1 Billions Doses to Serum Institute of India as part of COVAX Deal

Novavax Inc. (Nasdaq: NVAX) inked a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to supply up to […]

Novavax Makes Big Move Donating 1.1 Billions Doses to Serum Institute of India as part of COVAX Deal
1 week ago
Share

India’s Drug Regulator Gives Greenlight for Oxford Vaccine & Covaxin for Emergency Pandemic Use: Some Worry Not Enough Transparency

The Drugs Controller General of India (DCGI) issued emergency authorization for two vaccines, including ‘COVISHIELD’, produced by the Serum Institute […]

India’s Drug Regulator Gives Greenlight for Oxford Vaccine & Covaxin for Emergency Pandemic Use Some Worry Not Enough Transparency
2 months ago
Share

Serum Institute of India Chief Recommends Governments Shield Pharma from Vaccine Lawsuits

TrialSite reported on Nov. 30 that a volunteer participating in the ‘Covishield’ COVID-19 vaccine study in India sued the vaccine […]

Serum Institute of India Chief Recommends Governments Shield Pharma from Vaccine Lawsuits
2 months ago
Share

IAVI & Scripps Antibody IP Basis for Global Deal for Equitable Access to Fight COVID-19

A nonprofit scientific research organization known as IAVI, dedicated to addressing urgent unmet global health challenges, has spent years in […]

IAVI & Scripps Antibody IP Basis for Global Deal for Equitable Access to Fight COVID-19
4 months ago
Share

Chief of World’s Busiest Vaccine Manufacturer: The USA & China are ‘Crazy’ for Shunning COVAX Alliance

Adar Poonawalla leads perhaps the busiest vaccine production operation in the world. The billionaire and CEO of Serum Institute of India (SII) […]

Chief of World’s Busiest Vaccine Manufacturer The USA & China are ‘Crazy’ for Shunning COVAX Alliance
5 months ago
Share

Worlds Largest Vaccine Manufacturer Tightening Up Relationship to Study and Produce AZD1222

The Serum Institute of India (SII) recently partnered up with AstraZeneca and Oxford University to progress COVID vaccine candidate AZD1222 […]

Worlds Largest Vaccine Manufacturer Tightening Up Relationship to Study and Produce AZD1222
6 months ago
Share

Serum Institute of India, Gates Foundation & GAVI Partner for COVID-19 Vaccine At Risk Production for $3 Per Dose Low Income Access

India’s Serum Institute of India, the world’s busiest vaccine manufacturer as measured by volume, emerges as a worldwide key player […]

Serum Institute of India, Gates Foundation & GAVI Partner for COVID-19 Vaccine At Risk Production for $3 Per Dose Low Income Access
7 months ago
Share

Indian Council of Medical Research to Launch Major Vaccine Clinical Trials in India

Indian Council of Medical Research announced plans to conduct large-scale clinical trials of two TB vaccines including one developed in […]

Vials group and syringe on white table with background windows
2 years ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.